Reviva Pharmaceuticals Hldg Inc (RVPH)

$3.09 0.00 (0.00%)

16:00 EDT RVPH Stock Quote Delayed 30 Minutes

RVPH Stock Earnings: Reviva Pharmaceuticals Misses EPS for Q4 2023

By InvestorPlace Earnings Apr 15, 2024

RVPH stock results show that Reviva Pharmaceuticals missed analyst estimates for earnings per share the fourth quarter of 2023.

Brain Disease Cures: 3 Neuroscience Stocks Targeting Revolutionary Breakthroughs

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

More Articles

Volume:

Previous Close -

Market Cap 69.99M

PE Ratio -9.09

EPS -0.34

Volume (Avg. Vol.)

Day's Range -

52-Week Range $2.67 - $9.25

Dividend & Yield N/A (N/A)

RVPH Stock Predictions, Articles, and Reviva Pharmaceuticals Hldg Inc News

From InvestorPlace
From the Web

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer Aug 24, 2022

It's time to start the day with a breakdown of the biggest pre-market stock movers for Wednesday and the news moving those shares.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Aug 2, 2022

Good morning, trader! Join us this morning as we cover the biggest pre-market stock movers traders need to know about for Tuesday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

By William White, InvestorPlace Writer Apr 7, 2022

We're diving into the biggest pre-market stock movers for Thursday that investors are going to want to keep track of today.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer Jan 24, 2022

Welcome back, trader! It's time to get this week going with a breakdown of the biggest pre-market stock movers for Monday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Jan 11, 2022

Grab a cup of coffee and get ready for another busy day of trading as we start with the biggest pre-market stock movers for Tuesday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer Jan 10, 2022

Welcome back, trader! We're starting off the week with a breakdown of the biggest pre-market stock movers for Monday morning!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

By William White, InvestorPlace Writer May 27, 2021

We're starting off the day with a look at the biggest pre-market stock movers for Thursday, including winners and losers.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday Morning

By William White, InvestorPlace Writer Apr 27, 2021

Tuesday's here and InvestorsPlace.com is ready with a look at the biggest pre-market movers winning and losing this morning.

RVPH Stock: Why Reviva Pharmaceuticals Is Skyrocketing 90% on Monday

By Chris MacDonald, InvestorPlace Contributor Apr 26, 2021

Today, investors in RVPH stock saw some pretty massive gains, as the company announced impressive results for its schizophrenia drug.

Reviva Pharmaceuticals files for $200M mixed securities shelf (NASDAQ:RVPH)

From Seeking Alpha Feb 2, 2024

Reviva Pharmaceuticals files a prospectus for the sale of $200M mixed securities shelf, emphasizing that it is not an offer to sell.

AbbVie – Cerevel deal lifts Reviva, Karuna (NASDAQ:RVPH)

From Seeking Alpha Dec 7, 2023

AbbVie's (ABBV) $8.7B deal to buy Cerevel Therapeutics (CERE) boosts neurology-focused biopharmas Reviva Pharma (RVPH) and Karuna Therapeutics (KRTX). Read more here.

Reviva Pharma stock slips on $30M share sale (NASDAQ:RVPH)

From Seeking Alpha Nov 16, 2023

Reviva Pharmaceuticals (RVPH) fell ~6% Thursday after announcing agreements to sell ~5.9M shares of its common stock and warrants to raise $30M. Read more here.

Reviva posts late-stage data for schizophrenia candidate

From Seeking Alpha Oct 30, 2023

Reviva Pharmaceuticals (RVPH) on Monday reported positive results from its Phase 3 trial for schizophrenia drug brilaroxazine. Read more here.

Reviva Pharmaceuticals to join Russell Microcap index (NASDAQ:RVPH)

From Seeking Alpha Jun 26, 2023

Reviva Pharmaceuticals Holdings (RVPH) will be added to the Russell Microcap Index, effective after the market opens on Monday, June 26, 2023, following the conclusion of the 2023...

Reviva Pharmaceuticals Holdings (RVPH) Receives a Buy from Maxim Group

From TipRanks Nov 16, 2022

Maxim Group analyst Jason McCarthy maintained a Buy rating on Reviva Pharmaceuticals Holdings (RVPH – Research Report) yesterday and set a price target of $10...

ADVERTISEMENT